Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant <i>Pseudomonas aeruginosa</i>-Reference-Cited by-同舟云学术

Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa

Published:2023-03-14 Issue:4 Volume:9 Page:864-885
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Dhiman Shiv¹,Ramirez Danyel¹,Li Yanqi²,Kumar Ayush²^ORCID,Arthur Gilbert³,Schweizer Frank¹^ORCID

Affiliation:

1. Department of Chemistry, University of Manitoba, Winnipeg R3T 2N2, Manitoba, Canada

2. Department of Microbiology, University of Manitoba, Winnipeg R3T 2N2, Manitoba, Canada

3. Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg R3E 0J9, Manitoba, Canada

Funder

Institute of Infection and Immunity

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00549

Reference111 articles.

1. Antibacterial drug discovery in the resistance era

2. Antimicrobial resistance (AMR)

3. United, I. No Time to Wait–Securing the Future from Drug-Resistant Infections; Report to the Secretary General of the Nations, 2019.

4. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis;Antibiotics;2024-01-11

2. Amphiphilic tribasic galactosamines potentiate rifampicin in Gram-negative bacteria at low Mg++/Ca++concentrations;Bioorganic & Medicinal Chemistry Letters;2024-01

3. Gut Microbiota Composition of Insectivorous Synanthropic and Fructivorous Zoo Bats: A Direct Metagenomic Comparison;International Journal of Molecular Sciences;2023-12-09

4. A calcium sulphate/hydroxyapatite ceramic biomaterial carrier for local delivery of tobramycin in bone infections: Analysis of rheology, drug release and antimicrobial efficacy;Ceramics International;2023-11

5. Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa;ACS Omega;2023-08-01